Other substances

Ferroquine

An antimalarial.

Phase of research

Potential treatment - pre-clinical evidence

How it helps

Antiviral

Drug status

Experimental

1
 Supporting references
0
 Contradictory references
3
 AI-suggested references
0
 Clinical trials

General information

Ferroquine is a potential antimalarial drug (Wani et al., 2015). It inhobits feline coronavirus and SARS-CoV in vitro (Biot et al., 2006).

Ferroquine on PubChem

 

Structure image - Ferroquine

CN(C)CC1=C(C=[C-]C1)CNC2=C3C=CC(=CC3=NC=C2)Cl.C1C=CC=[C-]1.[Fe+2]

Supporting references

Link Tested on Impact factor Notes Publication date
Antimalarial drugs inhibit the replication of SARS-CoV-2: An in vitro evaluation
Small molecule In vitro 		Vero E6 cells; SARS-CoV-2 IHUMI-3 strain 4.59

The antimalarial drug inhibited SARS-CoV-2 in vitro at IC50 and IC90 similar to the concentrations reached during oral antimalarial treatment.

 Sep/08/2020

AI-suggested references

Link Publication date
In Vitro Evaluation of the Antiviral Activity of Methylene Blue Alone or in Combination against SARS-CoV-2.
Jul/06/2021
Computational Studies of Selected Transition Metal Complexes as Potential Drug Candidates against the SARS-CoV-2 Virus
Aug/11/2021
Broad spectrum anti-coronavirus activity of a series of anti-malaria quinoline analogues.
Jul/01/2021
Export (.csv)